i2E, Inc.

i2E, Inc. is a private, not-for-profit organization based in Oklahoma City, focused on supporting the growth of innovative small businesses in Oklahoma. Through its investment arm, Plains Ventures, i2E manages over $100 million in capital, providing funding and business development services to companies at various stages of growth. Since its inception in 1998, i2E has been instrumental in helping entrepreneurs commercialize technologies, launch new businesses, and access necessary capital.

The organization offers a range of services, including venture assessment, strategic consulting, and access to funding, assisting both new and existing businesses across diverse industries such as technology, healthcare, energy, and manufacturing. i2E's investment focus spans seed, early-stage, and growth-stage companies, with investments typically ranging from $200,000 to $1.5 million. Their portfolio includes companies in sectors like biotechnology, life sciences, consumer products, education, clean tech, information technology, advanced materials, aerospace, agriculture, and nanotechnology.

i2E's commitment to Oklahoma's entrepreneurial ecosystem is evident through its partnerships with entities like the Oklahoma Center for the Advancement of Science and Technology (OCAST) and the Oklahoma Seed Capital Fund. These collaborations aim to diversify the state's economy and create high-paying jobs by supporting innovative startups and small businesses. Notable successes include investments in companies such as Crescendo Bioscience, acquired for $270 million in 2014, and Selexys Pharmaceuticals, acquired by Novartis for $665 million in 2016. i2E continues to play a pivotal role in driving economic development and innovation within Oklahoma.